Post by A&O Shearman

Our Life Sciences Patents Monthly Roundup explores key developments shaping the patent and regulatory landscape. This month our experts review notable updates across the Unified Patent Court (UPC), Court of Justice of the European Union (CJEU), Germany, France and the United States, including: • UPC rulings clarifying compliance with injunctions and reaffirming access to injunctive relief • New CJEU references on the scope of the Supplementary Protection Certificate (SPC) Manufacturing Waiver export exemption • A German decision with potential implications for SPC protection in combination therapy contexts • French confirmation that non-exclusive licensees may bring infringement actions • A U.S. Supreme Court ruling on skinny labelling and inducement, alongside new FDA guidance on gene therapy development Go in-depth here: https://ow.ly/AiAB50ZiMmw #LifeSciences #UPC #AOShearman